Elizabeth Smith
Direttore/Membro del Consiglio presso Inceptor Bio LLC
Provenienza dei contatti di primo grado di Elizabeth Smith
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Biotechnology | 39 | |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC.
11
| Holding Company | Biotechnology | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Elizabeth Smith tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Founder General Counsel Director/Board Member General Counsel Public Communications Contact Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Administrative Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
LYELL IMMUNOPHARMA, INC. | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Stanford University | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
CELGENE | Biotechnology | President Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Chairman Founder Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CARDINAL HEALTH, INC. | Medical Distributors | President Director/Board Member Private Equity Investor | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Biotechnology | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
JW (CAYMAN) THERAPEUTICS CO. LTD | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Kincell Bio LLC
Kincell Bio LLC BiotechnologyHealth Technology Kincell Bio LLC provides clinical cell therapy manufacturing services. The company is based in Gainesville, FL. Bruce Thompson has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
Altos Labs, Inc.
Altos Labs, Inc. BiotechnologyHealth Technology Altos Labs is a biotechnology company that focuses on cellular rejuvenation programming to restore cell health and resilience. The company is based in Redwood City, CA. The company's goal is to reverse disease and transform medicine. Altos Labs was founded by Rick Klausner and Hans Edgar Bishop. The CEO is Hal V. Barron. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ILLUMINA, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Private Equity Investor | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member Founder | |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member | |
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
National Resilience, Inc.
National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Chairman Director/Board Member | |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
The Rockefeller University | College/University | Director/Board Member President | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Analyst | |
Kineticos Disruptor Fund IB4 LLC
Kineticos Disruptor Fund IB4 LLC BiotechnologyHealth Technology Kineticos Disruptor Fund IB4 LLC is a life sciences investment fund. The company was founded in 2020 and is headquartered in Raleigh, NC. | Biotechnology | Director/Board Member Director/Board Member | |
IKARIA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Neuvogen, Inc. | Director/Board Member Director/Board Member | ||
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 45 |
Svizzera | 3 |
Cina | 3 |
Taiwan | 2 |
Regno Unito | 2 |
Settori
Health Technology | 34 |
Consumer Services | 9 |
Finance | 4 |
Commercial Services | 3 |
Distribution Services | 2 |
Posizioni
Director/Board Member | 338 |
Corporate Officer/Principal | 133 |
Independent Dir/Board Member | 95 |
Chief Tech/Sci/R&D Officer | 55 |
Chairman | 52 |
Contatti più connessi
Insiders | |
---|---|
Robert Nelsen | 80 |
Anthony Evnin | 46 |
Maggie Wilderotter | 44 |
Thomas Daniel | 35 |
Patrick Yang | 28 |
Howard H. Pien | 27 |
Richard Klausner | 27 |
Jay Flatley | 27 |
Marc Tessier-Lavigne | 24 |
Mark R. Bamforth | 20 |
Hyam Levitsky | 18 |
George Fotiades | 17 |
Sunil Agarwal | 17 |
Hal Barron | 16 |
Robert Azelby | 15 |
- Borsa valori
- Insiders
- Elizabeth Smith
- Connessioni Società